BIOMAT Database Logo BIOMAT Database Logo

Treatment of acute myelogenous leukemia. 1995

H Ghaddar, and P Anderlini, and E Estey

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012074 Remission Induction Therapeutic act or process that initiates a response to a complete or partial remission level. Induction of Remission,Induction, Remission,Inductions, Remission,Remission Inductions
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015470 Leukemia, Myeloid, Acute Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES. Leukemia, Myelogenous, Acute,Leukemia, Nonlymphocytic, Acute,Myeloid Leukemia, Acute,Nonlymphocytic Leukemia, Acute,ANLL,Acute Myelogenous Leukemia,Acute Myeloid Leukemia,Acute Myeloid Leukemia with Maturation,Acute Myeloid Leukemia without Maturation,Leukemia, Acute Myelogenous,Leukemia, Acute Myeloid,Leukemia, Myeloblastic, Acute,Leukemia, Myelocytic, Acute,Leukemia, Myeloid, Acute, M1,Leukemia, Myeloid, Acute, M2,Leukemia, Nonlymphoblastic, Acute,Myeloblastic Leukemia, Acute,Myelocytic Leukemia, Acute,Myelogenous Leukemia, Acute,Myeloid Leukemia, Acute, M1,Myeloid Leukemia, Acute, M2,Nonlymphoblastic Leukemia, Acute,Acute Myeloblastic Leukemia,Acute Myeloblastic Leukemias,Acute Myelocytic Leukemia,Acute Myelocytic Leukemias,Acute Myelogenous Leukemias,Acute Myeloid Leukemias,Acute Nonlymphoblastic Leukemia,Acute Nonlymphoblastic Leukemias,Acute Nonlymphocytic Leukemia,Acute Nonlymphocytic Leukemias,Leukemia, Acute Myeloblastic,Leukemia, Acute Myelocytic,Leukemia, Acute Nonlymphoblastic,Leukemia, Acute Nonlymphocytic,Leukemias, Acute Myeloblastic,Leukemias, Acute Myelocytic,Leukemias, Acute Myelogenous,Leukemias, Acute Myeloid,Leukemias, Acute Nonlymphoblastic,Leukemias, Acute Nonlymphocytic,Myeloblastic Leukemias, Acute,Myelocytic Leukemias, Acute,Myelogenous Leukemias, Acute,Myeloid Leukemias, Acute,Nonlymphoblastic Leukemias, Acute,Nonlymphocytic Leukemias, Acute
D018572 Disease-Free Survival Period after successful treatment in which there is no appearance of the symptoms or effects of the disease. Survival, Disease-Free,Disease Free Survival,Survival, Disease Free

Related Publications

H Ghaddar, and P Anderlini, and E Estey
Treatment of acute myelogenous leukemia.
June 1995, The New England journal of medicine,
H Ghaddar, and P Anderlini, and E Estey
Treatment of acute myelogenous leukemia.
March 2002, Oncology (Williston Park, N.Y.),
H Ghaddar, and P Anderlini, and E Estey
Treatment of acute myelogenous leukemia.
June 1995, The New England journal of medicine,
H Ghaddar, and P Anderlini, and E Estey
[Treatment of acute myelogenous leukemia].
July 1992, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
H Ghaddar, and P Anderlini, and E Estey
Treatment of acute myelogenous leukemia.
April 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
H Ghaddar, and P Anderlini, and E Estey
The treatment of acute myelogenous leukemia.
January 1987, Haematology and blood transfusion,
H Ghaddar, and P Anderlini, and E Estey
New treatment for acute myelogenous leukemia.
January 2015, Expert opinion on pharmacotherapy,
H Ghaddar, and P Anderlini, and E Estey
Treatment of acute myelogenous leukemia in children.
January 1985, Medical oncology and tumor pharmacotherapy,
H Ghaddar, and P Anderlini, and E Estey
[Treatment of acute myelogenous leukemia in adults].
February 1972, [Rinsho ketsueki] The Japanese journal of clinical hematology,
H Ghaddar, and P Anderlini, and E Estey
Post-remission treatment of acute myelogenous leukemia.
January 1995, The New England journal of medicine,
Copied contents to your clipboard!